No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
489 |
4. Check minimum number of eventsNone |
489 |
5. Include endpointsNone |
489 |
6. Filter based on genotype QC (FinnGen only) |
478 |
Control definitions (FinnGen only)
- Control exclude
- AB1_ZOONOTIC_BACTERIAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Tularaemia
based on the number of shared cases.
Similar with more cases:
- Certain zoonotic bacterial diseases
- Tularaemia
- Certain zoonotic bacterial diseases
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4460 | 1976 | 2467 |
| Only index persons | 4103 | 1830 | 2273 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.07 |
| Only index persons | 0.08 | 0.07 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 46.83 | 48.39 | 45.50 |
| Only index persons | 46.01 | 47.63 | 44.71 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 478 | 233 | 245 |
| Unadjusted period prevalence (%) | 0.10 | 0.08 | 0.11 |
| Median age at first event (years) | 51.19 | 48.78 | 53.48 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 489
- Matched controls
- 4890
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A21.9
ICD-10 Finland
Tularaemia, unspecified
5278.1
273.7
238
*
A21.0
ICD-10 Finland
Ulceroglandular tularaemia
+∞
142.9
130
*
J01MA02
ATC
ciprofloxacin; systemic
5.8
79.4
330
1281
R50.9
ICD-10 Finland
Fever, unspecified
4.4
44.2
142
418
A21.2
ICD-10 Finland
Pulmonary tularaemia
+∞
31.6
30
*
A21.8
ICD-10 Finland
Other forms of tularaemia
+∞
23.1
22
*
A98.5
ICD-10 Finland
Haemorrhagic fever with renal syndrome
6.8
18.1
29
45
A21
ICD-10 Finland
Tularaemia
+∞
16.8
16
*
0210A
ICD-9 Finland
Tularaemia, Ulceroglandular tularaemia
+∞
16.8
16
*
J17.0*A21.2
ICD-10 Finland
Pneumonia (due to)(in) tularaemia
+∞
15.7
15
*
02100
ICD-8 Finland
Tularaemia, Glanduraris sive ulceroglandularis
+∞
13.6
13
*
0219X
ICD-9 Finland
Tularaemia, Unspecified tularaemia
+∞
13.6
13
*
WX720
NOMESCO Finland
Own respiration
3.9
12.7
39
107
WX704
NOMESCO Finland
Intubation
3.1
12.0
53
185
UDC00
NOMESCO Finland
Ear microscopy
2.9
10.6
51
187
0218X
ICD-9 Finland
Tularaemia, Other specified tularaemia
+∞
10.5
10
*
A21.7
ICD-10 Finland
Generalized tularaemia
+∞
10.5
10
*
SPAT1263
SPAT
Sampling
1.9
10.1
216
1455
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.7
9.8
55
218
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.2
9.6
26
65
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
9.6
119
666
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
9.2
66
296
SPAT1044
SPAT
Tympanometry
4.5
8.7
21
48
SPAT1324
SPAT
Screening procedure
2.2
8.4
75
369
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.8
8.2
149
942
XQ855, ,
SPAT
10.3
7.6
14
14
SPAT1255
SPAT
Intravenous administration of medicine
2.8
7.4
36
133
02109
ICD-8 Finland
Tularaemia, Unspecified
+∞
7.3
7
*
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.6
7.2
17
38
J01AA02
ATC
doxycycline; systemic
1.8
7.2
364
3029
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
6.7
195
1396
J01MA12
ATC
levofloxacin; systemic
1.9
6.5
96
564
SPAT1310
SPAT
Counselling related to known health issue
1.7
6.5
154
1041
SPAT1301
SPAT
No procedures
1.7
6.5
151
1016
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.8
6.5
33
125
SPAT1285
SPAT
Provision of consultation response
2.9
6.3
30
109
A21.1
ICD-10 Finland
Oculoglandular tularaemia
+∞
6.3
6
*
02107
ICD-8 Finland
Tularaemia, Suspecta
+∞
6.3
6
*
WVA20, ,
SPAT
3.8
6.3
19
52
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
6.2
107
659
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
57
63
10.11
47.81
1.4
1.1
—
—
—
0
0
49
5
108.68
45.70
1.7
1.0
860.00
—
titre
—
22
0
21
34
6.41
12.57
1.1
1.1
—
—
—
0
0
125
738
1.93
8.57
4.9
3.6
162.98
289.82
ng/l
0.57
100
569
83
434
2.10
7.95
1.9
1.8
—
—
—
0
0
31
101
3.21
7.85
1.5
1.6
—
—
—
0
0
191
1316
1.74
7.80
4.1
3.2
32.51
32.08
u/l
0.06
183
1258
25
73
3.56
7.49
1.6
1.5
—
—
—
0
0
81
431
2.05
7.39
1.9
1.7
—
—
—
0
0
21
56
3.87
7.15
1.4
1.5
—
—
—
0
0
29
97
3.12
7.04
1.5
1.6
—
—
—
0
0
248
1891
1.63
6.56
6.7
5.7
27.61
27.85
%
0.14
242
1787
245
1864
1.63
6.53
6.4
5.5
57.12
57.18
%
0.03
239
1766
174
1217
1.67
6.46
2.8
2.6
54.88
61.45
u/l
0.85
166
1130
18
47
3.94
6.31
1.4
1.4
—
—
—
0
0
18
47
3.94
6.31
1.4
1.4
—
—
—
0
0
23
73
3.26
6.09
1.3
1.7
—
—
—
0
0
23
73
3.26
6.09
1.3
1.7
—
—
—
0
0
216
1625
1.59
5.83
6.0
4.7
35.64
35.79
g/l
0.14
202
1524
100
616
1.78
5.81
1.9
1.8
—
—
—
0
0
21
65
3.33
5.79
1.4
1.5
—
—
—
0
0
285
2296
1.58
5.66
4.9
4.9
6.78
6.71
mmol/l
0.22
269
2136
198
1468
1.59
5.63
4.2
3.6
—
—
—
0
0
17
47
3.71
5.53
3.1
2.1
13.14
13.14
%
0.01
17
47
119
781
1.69
5.50
1.8
1.7
429.90
6144833.51
pmol/l
0.50
108
651
233
1803
1.56
5.45
10.9
12.5
1.24
1.24
inr
0.03
79
522
53
922
0.52
4.82
3.7
2.3
—
—
—
0
0
337
2879
1.55
4.71
5.6
4.0
13.32
11.46
mm/h
1.42
328
2652
440
4024
1.93
4.67
17.0
15.8
139.36
139.67
mmol/l
1.87
434
3913
440
4037
1.90
4.43
17.7
15.9
4.00
3.97
mmol/l
0.96
434
3922
23
89
2.66
4.37
3.3
4.2
21.12
24.90
mg/l
0.17
17
58
24
98
2.52
4.11
1.5
1.5
—
—
—
0
0
21
83
2.60
3.85
1.1
1.3
323.91
282.84
u/ml
0.20
11
43
300
2563
1.44
3.72
5.3
4.1
861.47
1799.50
e6/l
0.23
17
44
119
862
1.50
3.50
3.9
3.7
1.02
1.02
kg/l
0.06
24
111
21
88
2.45
3.44
1.0
1.3
—
—
—
0
0
231
1901
1.41
3.43
4.2
3.5
0.00
0.00
estimate
0.50
58
391
232
1932
1.38
3.11
4.2
3.5
0.00
0.00
estimate
-0.00
55
345
229
1906
1.38
3.07
5.6
4.7
0.00
0.00
estimate
-0.00
56
364
340
3024
1.41
3.02
8.8
7.4
74.84
78.06
u/l
0.75
330
2833
146
1129
1.42
3.01
5.0
4.1
21.38
20.97
%
0.12
68
525
265
2270
1.37
2.91
9.6
8.9
4.29
4.08
e9/l
0.68
251
1996
13
47
2.81
2.83
1.5
1.9
31.15
33.00
pg
0.81
13
47
18
78
2.36
2.78
1.8
1.2
1.77
12.60
e6/l
0.66
13
60
223
1872
1.35
2.74
7.2
6.9
1.21
1.21
mmol/l
0.42
191
1607
65
438
1.56
2.65
5.4
9.0
2.16
0.99
mmol/l
2.01
51
357
447
4227
1.67
2.62
12.0
10.1
29.24
27.15
u/l
0.86
440
4081
182
1489
1.35
2.62
3.6
3.6
45.24
38.49
ng/l
0.20
113
1034
16
68
2.40
2.58
3.0
2.2
13.96
15.93
%
—
10
32
8
20
4.05
2.57
2.9
2.2
—
—
—
0
0
5
7
7.20
2.55
1.4
1.4
—
—
—
0
0
464
4440
1.88
2.51
23.5
19.9
251.47
247.36
e9/l
0.66
459
4326
424
3971
1.51
2.48
16.8
13.7
28.96
23.28
mg/l
2.15
368
3119
464
4442
1.87
2.47
23.5
20.0
52.16
40.52
%
0.48
392
4165
8
21
3.85
2.47
1.8
1.3
—
—
—
0
0
10
32
3.17
2.45
1.2
1.1
—
—
—
0
0
9
28
3.25
2.31
1.2
1.3
12155.56
19519.11
e6/l
—
9
19
11
40
2.79
2.28
2.0
1.3
—
—
—
0
0
143
1150
1.34
2.25
2.5
2.1
227.92
268.65
u/l
0.15
134
1084
215
1845
1.30
2.10
2.8
2.6
—
—
—
0
0
86
645
1.40
2.08
1.2
1.3
24.99
32.52
iu/ml
0.32
34
214
147
1201
1.32
2.06
3.2
3.1
7.99
7.86
mmol/l
0.14
133
1016
82
612
1.41
2.04
1.1
1.3
9.73
11.34
u/ml
0.07
27
235
142
1158
1.32
2.01
3.9
3.8
3.21
9.42
mg/mmol
3.01
97
745
9
32
2.85
2.01
1.4
1.2
—
—
—
0
0
23
127
1.85
1.97
2.5
1.5
—
132.00
—
0
5
27
157
1.76
1.97
2.1
1.8
—
—
—
0
0
11
45
2.48
1.94
1.4
1.3
—
—
—
0
0
118
942
1.33
1.93
2.3
2.0
2.52
2.99
mg/l
1.41
110
802
23
128
1.84
1.93
2.3
3.1
—
—
—
0
0
235
2056
1.28
1.93
7.0
6.3
11.31
11.38
umol/l
0.03
222
1942
87
663
1.38
1.92
1.6
1.7
1259.33
1152.22
nmol/l
0.58
76
509
12
52
2.34
1.89
2.0
1.3
—
—
—
0
0
7
22
3.21
1.88
1.3
1.0
—
—
—
0
0
8
28
2.89
1.87
1.8
1.3
—
—
—
0
0
10
221
0.44
1.85
1.2
1.6
—
—
—
0
0
18
94
1.95
1.82
1.3
1.2
—
3.01
—
0
14
48
677
0.68
1.81
3.0
2.6
1.08
1.03
e6/l
0.06
29
355
168
1420
1.28
1.79
5.2
4.7
1.88
2.40
ug/l
1.06
162
1282
109
870
1.33
1.78
1.7
1.7
1.12
1.26
mg/l
0.24
93
665
349
3733
0.77
1.78
14.6
12.6
82.83
82.81
ml/min/173m2
0.01
285
3041
20
110
1.85
1.75
1.6
1.3
—
—
—
0
0
6
18
3.36
1.75
1.3
1.8
513.00
880.28
u/ml
—
6
18
46
644
0.68
1.67
3.1
2.7
0.80
2.35
e6/l
3.12
27
326
192
1670
1.25
1.57
3.2
2.6
133.54
125.80
ug/l
0.18
177
1540
284
2579
1.24
1.56
2.9
3.1
—
—
—
0
0
14
71
2.00
1.55
1.8
1.6
—
—
—
0
0
19
108
1.79
1.53
1.1
1.2
—
—
—
0
0
6
21
2.88
1.51
1.2
1.0
—
—
—
0
0
9
37
2.46
1.48
1.2
1.1
—
—
—
0
0
23
140
1.67
1.47
3.0
2.3
—
—
—
0
0
36
245
1.51
1.47
1.4
1.3
—
52.37
—
0
20
39
270
1.48
1.47
2.5
2.4
—
17.80
—
0
20
22
133
1.68
1.45
4.4
2.2
4873.22
3599.49
u/l
0.09
11
55
17
95
1.82
1.45
1.6
1.6
—
—
—
0
0
11
211
0.51
1.42
6.6
10.7
23.82
24.52
mmol/l
0.62
11
206
5
123
0.40
1.38
3.4
2.0
95.20
284.05
ug/l
—
5
116
401
3816
1.28
1.32
4.3
4.4
5.94
5.97
mmol/l
0.12
383
3493
9
43
2.11
1.31
1.4
1.3
—
—
—
0
0
6
24
2.52
1.30
1.0
1.3
—
—
—
0
0
6
24
2.52
1.30
1.0
1.3
—
—
—
0
0
5
18
2.80
1.29
2.0
1.3
—
—
—
0
0
32
453
0.69
1.26
7.8
6.9
—
—
—
0
0
315
2928
1.21
1.25
4.1
3.7
14.70
14.77
pmol/l
0.21
300
2640
12
63
1.93
1.23
1.0
1.1
—
—
—
0
0
5
19
2.65
1.22
2.0
1.3
—
—
—
0
0
18
109
1.68
1.20
1.8
1.8
—
—
—
0
0
6
26
2.32
1.19
3.3
2.2
728.33
615.90
e6/l
—
6
21
8
39
2.07
1.15
1.3
1.1
—
—
—
0
0
67
534
1.30
1.13
1.5
1.4
—
—
—
0
0
7
30
2.35
1.12
1.3
1.2
—
—
—
0
0
14
81
1.75
1.10
1.3
1.2
—
1.06
—
0
7
14
81
1.75
1.10
1.3
1.2
—
—
—
0
0
7
35
2.01
1.00
1.0
1.3
—
—
—
0
0
5
23
2.19
0.98
1.0
1.1
101.20
101.30
u/l
—
5
23
5
23
2.19
0.98
1.0
1.1
32.60
36.26
u/l
—
5
23
11
62
1.79
0.95
1.2
1.2
61.87
12.43
u/l
0.51
11
54
104
892
1.21
0.94
1.7
1.5
18.95
20.52
nmol/l
0.64
97
754
7
37
1.90
0.94
2.4
1.5
—
—
—
0
0
13
78
1.68
0.92
1.6
1.5
18876.00
18954.81
e6/l
0.00
13
58
14
86
1.65
0.92
1.6
1.7
—
—
—
0
0
19
127
1.52
0.90
1.3
1.5
0.59
0.11
iu/ml
—
5
29
101
869
1.20
0.89
1.2
1.2
1.10
1.76
u/ml
0.61
29
245
402
3874
1.21
0.87
4.3
4.2
1.43
1.44
mmol/l
0.18
390
3584
8
43
1.87
0.87
2.1
1.5
11.52
16.34
ug/l
—
8
43
39
499
0.76
0.86
2.4
2.1
—
—
—
0
0
26
353
0.72
0.85
4.0
7.3
1.26
1.39
mmol/l
0.51
26
344
57
464
1.26
0.84
3.0
3.0
5.53
8.84
umol/l
1.74
50
410
6
31
1.95
0.84
2.0
2.3
648.50
561.88
ml
—
6
17
6
32
1.89
0.82
1.0
1.3
242.17
171.84
pmol/l
—
6
32
66
549
1.23
0.82
2.5
2.2
2.46
2.33
g/l
1.25
61
512
21
293
0.70
0.81
2.1
2.7
75.40
68.98
ml/min/173m2
—
10
122
374
3591
1.18
0.80
5.0
4.4
1.91
1.89
mu/l
0.13
362
3275
12
74
1.64
0.79
1.6
1.5
—
—
—
0
0
36
279
1.31
0.78
1.5
1.6
—
—
—
0
0
403
3898
1.19
0.76
4.6
4.3
4.64
4.63
mmol/l
0.03
390
3628
96
1092
0.85
0.72
4.1
2.9
0.14
0.47
e6/l
3.46
82
794
9
56
1.62
0.72
2.4
1.5
—
—
—
0
0
10
60
1.68
0.72
1.2
1.3
—
—
—
0
0
30
230
1.32
0.71
1.2
1.4
—
—
—
0
0
5
26
1.93
0.71
1.0
2.1
—
—
—
0
0
5
26
1.93
0.71
1.0
2.1
—
—
—
0
0
12
181
0.65
0.70
2.1
2.2
0.64
0.64
%
0.01
12
181
17
118
1.46
0.70
1.4
1.9
—
—
—
0
0
5
27
1.86
0.68
2.2
1.3
—
—
—
0
0
7
44
1.60
0.65
1.9
2.2
—
—
—
0
0
14
95
1.49
0.64
1.5
1.2
—
—
—
0
0
16
112
1.44
0.64
1.4
1.4
—
—
—
0
0
5
29
1.73
0.64
1.4
1.7
141.80
75.90
umol/l
—
5
29
8
50
1.61
0.61
1.8
2.0
—
—
—
0
0
8
50
1.61
0.61
5.8
7.8
10.25
11.20
mg/l
—
8
45
373
3607
1.14
0.61
5.8
5.6
40.56
39.99
mmol/mol
0.55
362
3370
284
2702
1.12
0.60
3.5
3.2
46.54
51.54
u/l
0.50
266
2539
408
3971
1.17
0.60
4.9
4.8
2.78
2.75
mmol/l
0.19
392
3673
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
27
210
1.30
0.60
2.6
1.9
—
—
—
0
0
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
10
64
1.57
0.59
3.7
2.9
3.26
4.49
e9/l
—
10
64
6
37
1.63
0.55
2.3
1.5
1.10
1.29
promille
—
6
26
384
3729
1.14
0.55
4.0
3.9
1.27
1.30
mmol/l
0.39
370
3435
15
109
1.39
0.51
1.4
1.1
—
—
—
0
0
169
1574
1.11
0.51
2.4
2.2
79.66
76.35
nmol/l
0.73
159
1404
14
190
0.73
0.50
1.7
1.5
—
—
—
0
0
10
67
1.50
0.50
3.7
3.1
55.80
57.78
%
—
10
67
7
45
1.56
0.49
2.0
2.3
—
—
—
0
0
14
102
1.38
0.48
1.1
1.4
—
—
—
0
0
7
47
1.50
0.47
1.0
1.1
—
—
—
0
0
31
255
1.23
0.47
2.6
2.0
—
—
—
0
0
12
86
1.41
0.45
1.4
1.3
—
—
—
0
0
5
32
1.57
0.42
1.4
1.4
—
—
—
0
0
41
352
1.18
0.42
3.8
3.4
1.53
1.96
mmol/l
0.39
34
285
0
16
0.00
0.41
0.0
1.2
—
7.75
—
0
16
0
18
0.00
0.40
0.0
1.2
—
227.57
—
0
18
13
97
1.35
0.40
2.2
1.9
3.18
4.32
iu/l
—
5
31
45
392
1.16
0.39
2.8
4.5
3.95
41.53
ug/l
1.15
38
334
0
19
0.00
0.39
0.0
2.4
—
—
—
0
0
111
1031
1.10
0.36
5.0
3.7
0.00
0.01
estimate
0.69
55
352
9
121
0.74
0.35
1.0
1.3
—
—
—
0
0
6
43
1.40
0.35
1.2
1.2
—
—
—
0
0
129
1210
1.09
0.34
4.3
3.0
29.07
109.97
e6/l
0.82
116
902
40
453
0.87
0.32
2.1
2.0
—
—
—
0
0
11
141
0.78
0.29
1.4
1.9
—
—
—
0
0
10
76
1.32
0.28
2.9
1.8
—
—
—
0
0
77
830
0.91
0.28
2.2
2.9
0.60
0.78
ug/l
1.75
49
534
11
86
1.29
0.26
1.9
1.9
—
—
—
0
0
5
74
0.67
0.26
1.2
1.4
—
—
—
0
0
5
74
0.67
0.26
1.2
1.4
—
—
—
0
0
159
1523
1.07
0.25
2.1
1.9
95.78
95.34
pmol/l
0.04
89
785
177
1704
1.06
0.23
6.0
6.0
1.20
1.21
mmol/l
0.95
168
1565
5
39
1.28
0.23
1.0
1.0
—
—
—
0
0
105
995
1.07
0.22
3.7
2.7
356.77
6480.79
umol/l
3.76
99
866
115
1094
1.07
0.22
3.1
3.0
1596.82
1265.72
ng/l
0.27
103
925
57
527
1.09
0.22
2.7
2.2
18.87
23.94
%
1.94
40
455
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
20.92
—
0
12
0
12
0.00
0.21
0.0
1.2
—
425.71
—
0
7
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
5
43
1.16
0.21
1.0
1.9
—
—
—
0
0
5
43
1.16
0.21
1.0
1.9
—
—
—
0
0
5
43
1.16
0.21
1.0
1.9
—
—
—
0
0
9
113
0.79
0.20
1.2
1.1
—
—
—
0
0
9
115
0.78
0.20
1.2
1.1
—
—
—
0
0
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
21
238
0.88
0.19
3.2
3.7
4.15
1.59
mmol/l
1.46
15
177
13
153
0.85
0.18
1.5
2.0
—
—
—
0
0
146
1409
1.05
0.18
4.1
3.0
—
—
—
0
0
5
68
0.73
0.17
1.4
1.1
—
—
—
0
0
10
83
1.21
0.15
1.9
1.4
—
—
—
0
0
8
99
0.80
0.13
2.0
1.8
163.25
226.83
pmol/l
—
8
92
64
611
1.05
0.12
5.5
3.3
0.82
0.82
mmol/l
0.02
59
573
11
95
1.16
0.11
1.2
1.4
—
—
—
0
0
42
396
1.07
0.11
5.4
3.1
—
—
—
0
0
129
1257
1.04
0.10
3.8
3.3
2.34
2.35
mmol/l
0.26
120
1114
22
202
1.09
0.10
1.3
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
115
1.13
0.10
3.8
2.4
0.42
0.32
u/ml
—
6
65
5
48
1.04
0.09
2.6
3.2
2.88
3.49
nmol/l
—
5
48
21
196
1.07
0.07
1.0
1.0
—
—
—
0
0
9
84
1.07
0.07
1.9
1.4
—
—
—
0
0
9
100
0.90
0.06
1.0
2.6
0.00
0.00
g/l
—
9
95
9
102
0.88
0.06
1.0
2.6
0.00
0.00
g/l
—
9
96
39
375
1.04
0.06
1.8
1.6
—
—
—
0
0
109
1072
1.02
0.05
2.0
1.6
1.47
1.40
mmol/l
0.39
97
903
73
738
0.99
0.01
1.7
1.6
—
—
—
0
0
25
249
1.00
0.00
1.4
1.2
219.70
154.78
iu/ml
0.29
11
100
6
60
1.00
0.00
1.2
1.5
—
—
—
0
0
8
80
1.00
-0.00
1.8
1.2
0.60
0.85
nmol/l
—
8
67
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
5.1
—
—
—
0
0
11
110
1.00
-0.00
1.0
2.5
0.00
0.00
g/l
-0.00
11
104
5
59
0.85
-0.00
1.2
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
11.18
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_TULARAEMIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_TULARAEMIA | 0.971 [0.78, 1.21] | 0.798 |
| Birth year | 0.996 [0.99, 1.0] | 0.411 |
During the follow-up period (1.1.1998 — 31.12.2019), 131 out of 1400 females with AB1_TULARAEMIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_TULARAEMIA | 0.804 [0.68, 0.95] | 0.011 |
| Birth year | 0.985 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 193 out of 1871 males with AB1_TULARAEMIA died.
Mortality risk
Mortality risk for people of age
years, who have AB1_TULARAEMIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.079% | 0.134% |
| 5 | 0.564% | 0.855% |
| 10 | 1.485% | 2.14% |
| 15 | 2.888% | 4.126% |
| 20 | 4.936% | 7.341% |
Relationships between endpoints
↥Index endpoint: AB1_TULARAEMIA – Tularaemia
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data